title: The value of middle cerebral artery systolic velocity for initial and subsequent management in fetal anemia.
abstract: OBJECTIVE
  To evaluate the fetal middle cerebral artery Doppler waveform for the prediciton of anemia in the RhD-alloimmunized fetus.
  
  
  METHODS
  Doppler velocimetry of the fetal middle cerebral artery peak systolic velocity was measured in 52 non-hydropic, RhD-alloimmunized fetuses who underwent 103 cordocenteses. Normal values were obtained from 70 normal cases. The peak systolic velocity values were expressed as multiples of the median (MoM) for gestation. Hemoglobin threshold for developing hydrops was developed from 22 RhD-alloimmunized hydropic fetuses and severe anemia was defined as Hb< or =0.60 MoM. The most efficient threshold values for the prediction of severe anemia in groups with no prior transfusion and those with prior transfusion were obtained by constructing ROC curves.
  
  
  RESULTS
  The mean gestational age (+/-S.D.) at cordocentesis was 28.0 +/- 4.6 weeks. Severe anemia was noted in 53 (51.5%) occasions. At a threshold middle cerebral artery peak systolic velocity value of > or =1.35 MoM, the sensitivity for severe anemia detection was 100% with a false-positive rate of 18%. In sub-analysis, in patients with one or more prior transfusion a sensitivity of 97% and a false-positive rate of 14% obtained at a threshold of > or =1.45 MoM. In patients with no previous transfusion the sensitivity for severe anemia was 100%, with a false-positive rate of 9.1% at a threshold value of > or =1.35 MoM.
  
  
  CONCLUSIONS
  The middle cerebral artery peak systolic velocity can be used to time both the initial diagnostic procedure and retransfusion.
authors.affiliation: Hacettepe University, School of Medicine, Division of Maternal Fetal Medicine, Ankara, Turkey. oderen@ato.org.tr
authors.forename: Ozgür
authors.initials: O
authors.lastname: Deren
authors.forename: Lütfü
authors.initials: L
authors.lastname: Onderoglu
mesh_terms: D000740:Anemia / Q000000981:diagnostic imaging* / Q000209:etiology / Q000628:therapy; D017218:Cordocentesis; D005189:False Positive Reactions; D005260:Female; D005315:Fetal Diseases / Q000000981:diagnostic imaging / Q000628:therapy*; D005865:Gestational Age; D006801:Humans; D017078:Laser-Doppler Flowmetry; D020768:Middle Cerebral Artery / Q000196:embryology*; D011247:Pregnancy; D011446:Prospective Studies; D012372:ROC Curve; D012203:Rh Isoimmunization / Q000150:complications*; D012680:Sensitivity and Specificity; D014463:Ultrasonography